Skip to main content

Advertisement

Log in

Necrotizing soft tissue infections

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Necrotizing soft tissue infections are characterized by necrosis of skin and associated structures. Despite advances in the diagnosis and treatment of these infections, the mortality remains high. There have been increasing reports of necrotizing fasciitis caused by group A Streptococcus over the past decade. Recent information supports the role of superantigens in the pathogenesis of this infection. The approach to management requires expeditious evaluation with early surgery and appropriate antimicrobial agents. Limited data suggest that surgical debridement may be delayed in selected patients until the patient is stable by the use of intravenous immunoglobulin, which can neutralize superantigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Gorbach SL: Necrotizing skin and soft tissue infections. Part I: Necrotizing fasciitis. IDCP Guidel 1996, 5:406–411. This is a concise review (with an excellent table) of pertinent clinical manifestations of NF.

    Google Scholar 

  2. Gorbach SL: Necrotizing skin and soft tissue infections. Part II: Myositis, Meleney’s gangrene, pyomyositis, necrotizing cellulitis, nonclostridial cellulitis, and Fournier’s gangrene. IDCP Guidel 1996, 5:463. This is a concise review (with an excellent table) of pertinent clinical manifestations of necrotizing infections.

    Google Scholar 

  3. File TM Jr, Tan JS: Treatment of skin and soft tissue infections. Am J Surg 1995, 169:27S-33S.

    PubMed  Google Scholar 

  4. File TM Jr: Necrotizing soft tissue infections. In Expert Guide to Infectious Diseases. Edited by Tan JS. Philadelphia: American College of Physicians-American Society of Internal Medicine; 2002:618–633.

    Google Scholar 

  5. Trent JT, Kirsner RS: Necrotizing fasciitis. Wounds 2002, 14:284–292.

    Google Scholar 

  6. Callahan TE, Schecter WP, Horn JK: Necrotizing soft tissue infection masquerading as cutaneous abcess following illicit drug injection. Arch Surg 1998, 133:812–817; discussion 817–819.

    Article  PubMed  CAS  Google Scholar 

  7. Chen JL, Fullertn KE, Flynn NM: Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001, 33:6–15.

    Article  PubMed  CAS  Google Scholar 

  8. Jarrett P, Ha T, Oliver F: Necrotizing fasciitis complicating disseminated cutaneous herpes zoster. Clin Exp Dermatol 1998, 23:87–88.

    Article  PubMed  CAS  Google Scholar 

  9. Chan AT, Cleeve V, Daymond TJ: Necrotizing fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J 2002, 78:47–48.

    Article  PubMed  CAS  Google Scholar 

  10. Smith RJ, Berk SL: Necrotizing fasciitis and nonsteroidal antiinflammatory drugs. South Med J 1991, 84:785–787.

    Article  PubMed  CAS  Google Scholar 

  11. Barnham M, Anderson AW: Non-steroidal anti-inflammatory drugs: a predisposing fact for streptococcal bacteremia? Adv Exp Med Biol 1997, 418:145–147.

    PubMed  CAS  Google Scholar 

  12. Stevens DL: Could nonsteroidal anti-inflammatory drugs (NSAIDS) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995, 21:977–980.

    PubMed  CAS  Google Scholar 

  13. Guibal F, Moffat-Joy M, Terris B, et al.: Effects of diclofenac on experimental streptococcal necrotizing fasciitis in rabbit. Arch Dermatol Res 1998, 290:628–633.

    Article  PubMed  CAS  Google Scholar 

  14. Seal DV: Necrotizing fasciitis. Curr Opin Infect Dis 2001, 14:127–132. This is a review of recent information regarding NF caused by GAS or Vibrio species.

    Article  PubMed  CAS  Google Scholar 

  15. Elliott DC, Kufera JA, Myers RA: Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996, 224:672–683.

    Article  PubMed  CAS  Google Scholar 

  16. Giuliano A, Lewis F, Hadley K, Blaisdell FW: Bacteriology of necrotizing fasciitis. Am J Surg 1977, 134:52–57.

    Article  PubMed  CAS  Google Scholar 

  17. Brook I: Synergistic aerobic and anaerobic infections. Clin Ther 1987, 20(Suppl A):19–35.

    Google Scholar 

  18. Childers BJ, Potyondy LD, Nachreiner R, et al.: Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 2002, 68:109–116. This is a review of recent experience of managing NF from a single center. The mortality rate was 28%.

    PubMed  Google Scholar 

  19. Lin C, Yeh FL, Lin JT, et al.: Necrotizing fasciitis of the head and neck: an analysis of 47 cases. Plast Reconstr Surg 2001, 107:1684–1693.

    Article  PubMed  CAS  Google Scholar 

  20. Kiliç A, Aksoy Y, Kiliç L: Fournier’s gangrene: etiology, treatment, and complications. Ann Plast Surg 2001, 47:523–527.

    Article  PubMed  Google Scholar 

  21. File TM Jr, Tan JS: Group A streptococcus necrotizing fasciitis. Comp Ther 2000, 26:73–81.

    Article  Google Scholar 

  22. Stevens DL: Invasive streptococcal infections. J Infect Chemother 2001, 7:69–80. This is an excellent review of the pathogenesis and management of invasive GAS infections.

    Article  PubMed  CAS  Google Scholar 

  23. Norrby-Teglund A, Thulin P, Gan BS, et al.: Evidence for superantigen involvement in severe group A streptococcal tissue infections. J Infect Dis 2001, 184:853–860.

    Article  PubMed  CAS  Google Scholar 

  24. Sharkawy A, Low DE, Saginur R, et al.: Severe group A streptococcal soft-tissue infections in Ontario: 1992–1996. Clin Infect Dis 2002, 34:454–460. This is the largest published population surveillance study of GAS NF. The incidence has increased from 1992 to 1996. Risk factors for mortality included old age, hypotension at diagnosis, and the presence of underlying illnesses.

    Article  PubMed  Google Scholar 

  25. Dahl PR, Perniciaro C, Holmkvist KA, et al.: Fulminant group A streptococcal necrotizing fasciitis: clinical and pathologic findings in 7 patients. J Am Acad Dermatol 2002, 47:489–492.

    Article  PubMed  Google Scholar 

  26. DiPersio JR, File TM, Stevens DL, et al.: Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis 1996, 22:490–495.

    PubMed  CAS  Google Scholar 

  27. Gamba MA, Martinelli M, Schaad HJ, et al.: Familial transmission of a serious disease-producing group A streptococcus clone: case report and review. Clin Infect Dis 1997, 24:1118–1121.

    PubMed  CAS  Google Scholar 

  28. Kaul R, McGeer A, Low D, et al.: Population-based surveillance group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventyseven cases. Am J Med 1997, 103:18–24.

    Article  PubMed  CAS  Google Scholar 

  29. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 1993, 269:390–391. This is a consensus definition from the Centers for Disease Control and Prevention.

  30. Gardan M, Low DE, Saginur R, Miller MA: Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Int Med 1998, 158:1704–1708.

    Article  Google Scholar 

  31. Bodemer C, Panhans A, Chretien-Marquet B, et al.: Staphylococcal necrotizing fasciitis in the mammary region in childhood: a report of five cases. J Pediatr 1997, 131:466–469.

    PubMed  CAS  Google Scholar 

  32. Holow KD, Harner RC, Fontenelle LJ: Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention. J Am Coll Surg 1996, 183:329–334.

    Google Scholar 

  33. Furusu A, Yoshizuka N, Abe K, et al.: Aeromonas hydrophila necrotizing fasciitis and gas gangrene in a diabetic patient on haemodialysis. Nephrol Dial Transplant 1997, 12:1730–1734.

    Article  PubMed  CAS  Google Scholar 

  34. Schreuder F, Chatoo M: Another cause of necrotizing fasciitis? J Infect 1997, 35:177–178.

    Article  PubMed  CAS  Google Scholar 

  35. Zipper RP, Bustamante MA, Khatib R: Serratia marcescens: a single pathogen in necrotizing fasciitis. Clin Infect Dis 1996, 23:648–649.

    PubMed  CAS  Google Scholar 

  36. Reyzelman AM, Lipsky BA, Hadi SA, et al.: The increased prevalence of severe necrotizing infections caused by non-group A streptococci. J Am Podiatr Med Assoc 1999, 89:454–457.

    PubMed  CAS  Google Scholar 

  37. Sharma M, Khatib R, Fakih M: Clinical characteristics of necrotizing fasciitis caused by group G streptococcus: case report and review of the literature. Scand J Infect Dis 2002, 3:468–471.

    Article  Google Scholar 

  38. Ballon-Landa GR, Gherardi G, Beall B, et al.: Necrotizing fasciitis due to penicillin-resistant streptococcus pneumoniae: case report and review of the literature. J Infect 2001, 42:272–277.

    Article  PubMed  CAS  Google Scholar 

  39. Frick S, Cerny A: Necrotizing fasciitis due to streptococcus pneumoniae after intramuscular infection of nonsteroidal anti-inflammatory drugs: report of 2 cases and review. Clin Infect Dis 2001, 33:740–744.

    Article  PubMed  CAS  Google Scholar 

  40. M’Rad MB, Brun-Buisson C: A case of necrotizing fasciitis due to Streptococcus pneumoniae following topical administration of nonsteroidal anti-inflammatory drugs. Clin Infect Dis 2002, 35:775–776.

    Article  PubMed  Google Scholar 

  41. Hossain A, Reis ED, Soundararajan K, et al.: Nontropical pyomyositis: analysis of eight patients in an urban center. Am Surg 2000, 66:1064–1066.

    PubMed  CAS  Google Scholar 

  42. Kramer LM, Doering LV: Necrotizing fasciitis: a case of clostridial myonecrosis. Am J Crit Care 2001, 10:181–187.

    PubMed  CAS  Google Scholar 

  43. Majeski J, Majeski E: Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997, 90:1065–1068. This is an observational study that demonstrated the usefulness of diagnostic fascial biopsy.

    Article  PubMed  CAS  Google Scholar 

  44. Wall DB, deVirgilis C, Black S, Klein SR: Objective criteria may assist in distinguishing necrotizing fasciitis from non-necrotizing soft tissue infection. Am J Surg 2000, 179:17–21.

    Article  PubMed  CAS  Google Scholar 

  45. Simonart T, Simonart JM, Derdelinckx I, et al.: Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 2001, 32:E9-E12.

    Article  PubMed  CAS  Google Scholar 

  46. Schmid MR, Kossmann T, Duewel S: Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol 1998, 170:615–620.

    PubMed  CAS  Google Scholar 

  47. Norrby-Teglund A, Norrby SR, Low DE: The treatment of severe group A streptococcal infections. Curr Infect Dis Rep 2003, 5:28–37. This is an excellent review of recent developments of the pathogenesis and therapy of severe GAS infection.

    Article  PubMed  Google Scholar 

  48. McHenry CR, Piotrowski JJ, Petrinic D, et al.: Determinants of mortality for necrotizing soft tissue infections. Ann Surg 1995, 221:556–563.

    Article  Google Scholar 

  49. Stevens DL: Necrotizing fasciitis: Don’t wait to make a diagnosis. Infect Med 1997, 14:684–688.

    Google Scholar 

  50. Muller MP, McGeer A, Low DE, Ontario Group A Streptococcal Study Group: Successful outcomes in six patients treated conservatively for suspected necrotizing fasciitis (NF) due to group A streptococcus (GAS). Poster presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy Abstracts. Chicago, IL; September 22–25, 2001.

  51. Low DE: New concepts in the therapy of severe streptococcal infections. Poster presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy Abstracts. San Diego, CA; September 27–30, 2002.

  52. Stevens DL, Gibbons AE, Bergstrom R, Winn V: The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988, 158:23–28.

    PubMed  CAS  Google Scholar 

  53. Zimbelman J, Palmer A, Todd J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive streptococcus pyogenes infection. Pediatr Infect Dis J 1999, 18:1096–1100.

    Article  PubMed  CAS  Google Scholar 

  54. Norrby-Teglund A, Kaul R, Low DE, et al.: Plasma from patients with severe group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigeninduced T cell proliferation and cytokine expression. J Immunol 1996, 156:3057–3064.

    PubMed  CAS  Google Scholar 

  55. Kaul R, McGeer A, Norrby-Teglund A, et al.: Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 1999, 28:800–807. This is an observational study (with historic controls) that supports the use of IVIG for streptococcal TSS (including NF).

    PubMed  CAS  Google Scholar 

  56. Basma H, Norrby-Teglund A, Guedez Y, et al.: Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 1999, 67:1871–1877.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

File, T.M. Necrotizing soft tissue infections. Curr Infect Dis Rep 5, 407–415 (2003). https://doi.org/10.1007/s11908-003-0021-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-003-0021-y

Keywords

Navigation